HIV Mutation Detail Information

> Y181C Search Result


Mutation Information
Mutation Site Y181C
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Relevant Drug doravirine (DOR);NNRTIs
Literature Information
PubMed PMID 27539455
Published Year 2016
Journal Infectious diseases and therapy
Title New Antiretroviral Treatment for HIV.
Author Badowski ME,Pérez SE,Biagi M,Littler JA
Evidence Doravirine has been shown to maintain in vitro activity against the common NNRTI resistance mutations K103N, Y181C, G190A, E101K, E138K, and K103N/Y181C.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation